MATS VADIM 4
4 · Hoth Therapeutics, Inc. · Filed Dec 26, 2019
Insider Transaction Report
Form 4
MATS VADIM
Director
Transactions
- Other
Options
2019-12-24+35,000→ 35,000 totalExercise: $5.26From: 2019-12-24Exp: 2029-12-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.